Fulgent Genetics, Inc. provided earning guidance for second quarter of 2022. For the second quarter of 2022, the company expects Total Revenue of approximately $125 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.08 USD | -1.24% | -6.62% | -27.33% |
03/05 | Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024 | |
03/05 | Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.33% | 639M | |
-20.70% | 7.83B | |
+0.14% | 2.58B | |
-8.23% | 2.48B | |
-40.47% | 2.46B | |
-13.91% | 1.84B | |
-21.56% | 1.53B | |
-42.17% | 1.22B | |
+16.01% | 1.2B | |
+14.92% | 961M |
- Stock Market
- Equities
- FLGT Stock
- News Fulgent Genetics, Inc.
- Fulgent Genetics, Inc. Provides Earning Guidance for Second Quarter of 2022